Resting Heart Rate and Your Genetics

Written by Scott Peeples, BS Biomedical Sciences · ExomeDNA Founder Reviewed by ExomeDNA Editorial Process Last reviewed: May 26, 2026

The RR interval — the time between successive heartbeats on an electrocardiogram — is the inverse of resting heart rate and a fundamental measure of cardiac rhythm and autonomic nervous system tone. GJA1, MYH6, and GPR133 are among the genetic signals identified for RR interval duration in genome-wide research spanning isolated European populations and large ECG meta-analyses.^[1][2] Below: how inherited variation in cardiac conduction and pacemaker biology genes shapes resting heart rate, and what the evidence reveals about this cardiovascular trait.

What is resting heart rate and the RR interval?

The RR interval is the time in milliseconds between two consecutive R-wave peaks on an electrocardiogram — the electrical signature of ventricular depolarization with each heartbeat. Resting heart rate in beats per minute is calculated as 60,000 divided by the RR interval in milliseconds. A longer RR interval corresponds to a slower resting heart rate: an RR interval of 1,000 ms equals 60 bpm; 750 ms equals 80 bpm.

The cardiac pacemaker is the sinoatrial (SA) node — a cluster of specialized cardiomyocytes in the right atrium that spontaneously depolarize at a rate that sets heart rhythm. The SA node's firing rate is continuously modulated by the autonomic nervous system: parasympathetic (vagal) input via the vagus nerve slows the SA node by releasing acetylcholine, reducing firing rate; sympathetic input accelerates it through norepinephrine. A longer resting RR interval typically reflects stronger vagal tone, better aerobic fitness, or genetic factors in intrinsic cardiac pacemaker biology.

The clinical significance of resting heart rate as a cardiovascular biomarker is well established. Resting heart rate consistently above 75–80 bpm associates with higher all-cause and cardiovascular mortality in large population cohorts. Athletes with high aerobic fitness often have resting heart rates of 40–55 bpm, reflecting efficient stroke volume and high vagal tone. A genetic tendency toward a longer RR interval — slower resting heart rate — is generally a favorable cardiovascular indicator.

The genetics of resting heart rate

The genetic landscape of resting heart rate spans cardiac structural biology, electrical conduction, and autonomic signaling. GJA1, MYH6, GPR133, and CD34 are among the genetic signals identified for RR interval in genome-wide analyses.^[1][2]

The GPR133 locus reached genome-wide significance (p = 3.9×10⁻⁸) for RR interval in 2,325 individuals from three European genetically isolated populations in the EUROSPAN project (Marroni et al. 2009, Circ Cardiovasc Genet) — one of the first confirmed genome-wide significant loci for resting heart rate, implicating an adhesion G-protein-coupled receptor in cardiac rhythm biology.^[1]

GJA1 encodes connexin 43 (Cx43) — the dominant gap junction protein in the ventricular and conduction system myocardium. Gap junctions are intercellular channels that allow the direct passage of electrical current between cardiomyocytes, propagating the action potential at the speeds required for coordinated cardiac contraction. GJA1/Cx43 is expressed in the SA node, AV node, and ventricular myocardium, where its expression levels and channel kinetics influence conduction velocity and effective refractory periods. Variants near GJA1 in heart rate GWAS data reflect the heritable component of gap junction-mediated cardiac conduction biology.^[1][2]

A genome-wide meta-analysis of approximately 30,000 samples identified seven novel loci across four electrocardiographic traits — PR interval, QRS duration, QT interval, and RR interval — confirming that each major cardiac rhythm parameter has distinct and overlapping genetic architectures involving cardiac pathway genes and regulatory networks (van Setten et al. 2019, Eur J Hum Genet).^[2]

MYH6 — myosin heavy chain 6, encoding alpha-cardiac myosin heavy chain (αMHC) — is expressed primarily in the adult atria and the SA node region. αMHC sets the contractile kinetics of atrial cardiomyocytes and contributes to the intrinsic mechanical properties of the SA node region. Rare MYH6 mutations cause sick sinus syndrome (pacemaker dysfunction), atrial fibrillation, and dilated cardiomyopathy; common GWAS variants near MYH6 reflect heritable atrial myosin biology underlying normal variation in resting heart rate. CD34, a cell-surface glycoprotein known for its role in hematopoietic stem cell biology and endothelial adhesion, appears as the top-ranked locus in fine-mapping of this trait; its specific mechanism at this chromosomal locus in cardiac rhythm regulation is not yet fully characterized. CEP85L (centrosomal protein 85L) and SYT10 (synaptotagmin 10, a calcium sensor for neuropeptide release in neuroendocrine cells) appear at additional loci, reflecting the diverse cellular biology that GWAS captures alongside the more mechanistically understood cardiac conduction signals.

What the research says

Research base: Moderate. The genetic architecture of resting heart rate here is supported by two genome-wide analyses: the EUROSPAN project of 2,325 individuals from isolated European populations (Marroni et al. 2009, Circ Cardiovasc Genet)^[1] and a 30,000-sample ECG meta-analysis identifying seven novel ECG loci (van Setten et al. 2019, Eur J Hum Genet).^[2] Moderate confidence reflects the modest sample sizes of both studies relative to current GWAS standards and the restriction to European ancestry. Larger and more diverse heart rate GWAS have since expanded the known loci substantially; the findings supporting this profile represent an earlier evidence base. See our methodology page for how we evaluate and apply genetic evidence in your ExomeDNA profile.

How resting heart rate genetics affects health

Resting heart rate is one of the most validated cardiovascular biomarkers in population medicine. Chronically elevated resting heart rate — above approximately 75–80 bpm — associates with higher risk of cardiovascular events, hypertension development, and all-cause mortality across major cohort studies. The mechanisms are direct: higher heart rate means more cardiac work cycles per minute, cumulative arterial wall stress from pulsatile pressure, and less time in diastole — the resting phase when coronary arteries fill with oxygenated blood. Over decades, these translate to greater cumulative cardiac wear and accelerated atherosclerosis.

A genetic tendency toward a longer RR interval — slower resting heart rate — reflects inherited cardiac biology favoring lower pacemaker firing rates or stronger vagal modulation. This tendency aligns with the high-fitness phenotype: endurance athletes with high vagal tone from years of aerobic training typically have the slowest resting heart rates in any population, often below 50 bpm. The genetic contribution to resting heart rate and the training-adapted contribution are distinct but share underlying cardiovascular physiology in their protective implications.

GJA1's role in gap junction-mediated conduction connects this trait to arrhythmia susceptibility: the same inherited variation in connexin 43 expression that shapes resting heart rate also affects the substrate for atrial fibrillation and other conduction abnormalities. MYH6's SA node biology similarly links RR interval genetics to the risk of sick sinus syndrome and related pacemaker disorders at the extreme end of the genetic architecture.

Working with your resting heart rate result

What research suggests about resting heart rate management

• Regular aerobic exercise: the most evidence-supported lifestyle intervention for lowering resting heart rate. Sustained aerobic training increases vagal tone and cardiac stroke volume, reducing the heart rate needed to maintain cardiac output — each month of consistent aerobic training typically reduces resting heart rate by 1–3 bpm.^[2]
• Consistent measurement: resting heart rate should be measured the same way each time — ideally first thing in the morning before rising — for meaningful tracking; single-point measurements during the day are highly variable with activity and stress.
• Caffeine and stimulants: caffeine acutely elevates heart rate through sympathomimetic effects; habitual heavy use maintains chronically elevated sympathetic tone.
• Sleep quality: poor sleep and sleep deprivation elevate sympathetic nervous system activity and resting heart rate; consistent sleep adequacy supports lower baseline heart rate.
• Stress management: chronic psychological stress maintains elevated sympathetic drive, raising resting heart rate over time; practices that activate the parasympathetic system can measurably reduce resting rate.
• Body weight management: excess body mass increases cardiac output requirements, driving chronically higher resting heart rates independent of fitness level.

Related traits and genes

Resting heart rate genetics connects directly to Heart Rate Variability, which measures beat-to-beat variation in RR intervals — a more sensitive measure of autonomic nervous system balance that shares overlapping genetic architecture with mean RR interval. QT Interval covers ventricular repolarization, another ECG timing parameter with partially shared genetic signals. Atrial Fibrillation Risk connects through MYH6 and GJA1 — both genes are implicated in atrial fibrillation as well as heart rate regulation, reflecting the shared biology of cardiac rhythm and arrhythmia susceptibility.

For cardiovascular outcomes, Cardiovascular Disease Risk is the primary downstream trait influenced by resting heart rate trajectory over time. Resting Blood Pressure shares the autonomic and vascular biology that shapes both heart rate and blood pressure as coupled cardiovascular parameters. Aerobic Capacity (VO2 Max) connects the fitness biology through which training-induced vagal tone and resting heart rate improvements are achieved.

Frequently asked questions

What is the RR interval and how does it relate to heart rate?

The RR interval is the time in milliseconds between consecutive R-wave peaks on an ECG — the electrical signature of each heartbeat. Resting heart rate in bpm equals 60,000 divided by the RR interval in milliseconds. A longer RR interval means a slower heart rate: 1,200 ms = 50 bpm (athletic range); 857 ms = 70 bpm (average healthy adult); 667 ms = 90 bpm (elevated). Genetics, fitness, and autonomic tone all contribute to where an individual's resting RR interval falls.

Why is a slower resting heart rate generally considered favorable?

A slower resting heart rate reflects efficient cardiac function and strong vagal (parasympathetic) tone. Each cardiac cycle creates mechanical stress on arterial walls and demands coronary artery filling time during diastole. At lower heart rates, each beat delivers more blood per stroke (higher stroke volume), total cardiac work is lower per unit of cardiac output, and coronary arteries have more time to perfuse. Population studies consistently show that resting heart rates above 75–80 bpm associate with higher cardiovascular mortality, while rates in the 50–65 range associate with the best long-term cardiovascular outcomes.

What does GJA1 (connexin 43) do in heart rate regulation?

GJA1 encodes connexin 43, the primary gap junction protein in the heart's conduction system. Gap junctions are protein channels that span the membranes between adjacent cardiomyocytes, allowing electrical current — action potentials — to flow directly from cell to cell. This coupling is what allows the sinoatrial node's pacemaker signal to spread rapidly and synchronously through the atria, then through the atrioventricular node and ventricular myocardium. Variants affecting GJA1 expression or channel kinetics alter conduction velocity and effective refractory periods, contributing to individual differences in resting heart rate and arrhythmia susceptibility.

What does MYH6 do and why does it appear in heart rate genetics?

MYH6 encodes alpha-cardiac myosin heavy chain (αMHC), the dominant myosin isoform in the adult atria and the sinoatrial node region of the human heart. αMHC sets the rate of cross-bridge cycling in atrial cardiomyocytes, influencing contractile kinetics. The SA node's specialized cardiomyocytes use this atrial myosin program, and variants in MYH6 that affect αMHC function alter intrinsic pacemaker properties. Rare MYH6 mutations cause sick sinus syndrome and atrial fibrillation; common GWAS variants represent subtler inherited shifts in atrial-type cardiac biology that contribute to normal heart rate variation.

Can lifestyle changes override genetic heart rate tendencies?

Yes, substantially. Resting heart rate is among the most trainable cardiovascular parameters — regular aerobic exercise can lower resting heart rate by 10–20 bpm in sedentary individuals over months of training, independent of genetic starting point. A genetic tendency toward a somewhat higher heart rate does not constrain what aerobic fitness can achieve. Conversely, a genetic advantage for lower resting heart rate does not protect against the heart rate elevation that follows deconditioning from inactivity. Genetics sets a tendency; lifestyle determines where within the achievable range an individual operates.

References

1. Marroni F, et al. (2009). A genome-wide association scan of RR and QT interval duration in 3 European genetically isolated populations: the EUROSPAN project. Circ Cardiovasc Genet. PMID: 20031603. DOI: 10.1161/CIRCGENETICS.108.833806.
2. van Setten J, et al. (2019). Genome-wide association meta-analysis of 30,000 samples identifies seven novel loci for quantitative ECG traits. Eur J Hum Genet. PMID: 30679814. DOI: 10.1038/s41431-018-0295-z.

Data sources:

• GWAS Catalog (NHGRI-EBI, accessed 2026-05-26)
• Open Targets Platform (CC0 1.0, accessed 2026-05-26)
• ClinVar (NCBI, accessed 2026-05-26) — entries at ≥2-star review status
• ClinGen Gene-Disease Validity (CC0 1.0, accessed 2026-05-26)

This page is published by the ExomeDNA Research Team. Last reviewed: 2026-05-26.